Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction

NCT04383262 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Laryngopharyngeal Reflux

Interventions

DRUG: Fosamprenavir Calcium
OTHER: Placebo

Sponsor

Medical College of Wisconsin